The leaders of the provincial health and health Committee led a team to visit Lijiexun for a discussion and research!


Time:

2023-04-07

In warm spring in April, with concern for Fujian pharmaceutical enterprises, on April 6, Yang Minhong, secretary of the party group and director of the Provincial Health Commission, led a team composed of members of the Provincial Health Commission, the Provincial Medical Insurance Bureau, the Provincial Department of Industry and Information Technology, and the Provincial Food and Drug Administration Bureau to investigate Lijiexun Pharmaceutical, a key pharmaceutical enterprise, accompanied by major leaders at the city and county levels.

The leaders of the provincial health and health Committee led a team to visit Lijiexun for a discussion and research!

Warm Spring April, with concern for Fujian pharmaceutical enterprises, on April 6, Yang Minhong, party secretary and director of the Provincial Health Commission, led a research team composed of members of the Provincial Health Commission, the Provincial Health Insurance Bureau, the Provincial Department of Industry and Information Technology and the Provincial Food and Drug Administration to investigate Lijiexun Pharmaceutical, a key pharmaceutical enterprise, accompanied by major leaders at the city and county levels.

REJUVENATION

01 Field visit

Secretary Yang and his party were accompanied by Lin Yuan, chairman and general manager of the company field inspection of the company's modern freeze-dried powder injection production workshop and supporting advanced production equipment. Lin Yuan, chairman and general manager of the company's exhibition hall, briefly reported the company's development process, R & D innovation, key products, marketing market, high-end talent team, future planning and other basic information. Lin Yuan, chairman of

Lijiexun, introduced the current situation of enterprise development to the research group

Since its establishment, Lijiexun has been adhering to the concept of "doing good medicine for health", insisting on improving human health level as the goal, and taking R & D innovation as the core driving force of enterprise development, in response to the major needs of the development of the industry, a multi-level research and development pipeline with innovative drugs and high-end pharmaceutical preparations as the mainstay, supplemented by high-quality generic drugs and generic drug consistency evaluation, has been formed to continuously promote the research and development of new products.

Up to now, Lijiexun has obtained 22 invention patents, including 4 PCT international invention patents; Won 2 provincial science and technology progress awards (second prize and third prize); it has established four provincial technology platforms, including "Fujian Province High-end Pharmaceutical Preparation Shanhai Collaborative Innovation Center" and "Fujian Province Freeze-dried Powder Injection Enterprise Engineering Technology Research Center.

Yang Shuji and his party affirmed Lijiexun Pharmaceutical's efforts and achievements in taking root in Zherong for 26 years, insisting on research and development and innovation, continuously improving and strengthening the biological medicine industry, and building its own national brand.

REJUVENATION

02 In-depth investigation

Subsequently, the participants held a symposium, and Secretary Yang gave a brief explanation on the purpose of the investigation. Chairman Lin Yuan made a key report on the current problems and suggestions of the enterprise. Participants discussed from supporting the development of the biomedical industry, introducing high-end talents, and building a government-enterprise service platform. At the meeting, the research team and its party also inquired in detail about the research and development process of Lijiexun Pharmaceutical in new therapeutic fields such as anti-allergy and anti-virus, as well as the long-term sustained and controlled release high-end technology fields, and the production and sales of key products such as citicoline sodium tablets and exclusive Pseudostellaria heterophylla series products.

Symposium Site

# At the end of the 119 meeting, Secretary Yang mentioned: "The research team should cooperate with each other, cooperate with each other to do a good job in related work, strive for more policies and resources, and effectively help pharmaceutical companies solve practical difficulties." And encourage the future development of Lijiexun to continue to adhere to technological innovation, pay close attention to the quality of production, and make greater contributions to the development of Fujian biomedicine.

Provincial Health Committee Party Secretary and Director Yang Minhong spoke at the symposium

Chairman Lin Yuan said that our company will further unify our thinking, define our goals, keep pace with the times with firmer beliefs, constantly innovate, and take practical actions to help the development of Fujian's biomedical industry.

Management Headquarters: Fuzhou Minhou County Software Park Area F Building

Production Base: Lijiexun Pharmaceutical

, No. 1 Zherong County Pharmaceutical Industry Road, Ningde City Tel: 0591-83376724